BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

MicroVention, Inc. And Terumo Corporation Announce Completion Of Merger


3/30/2006 10:37:27 AM

ALISO VIEJO, Calif., March 30 /PRNewswire/ -- MicroVention, Inc., a leading developer, manufacturer and marketer of minimally invasive treatments for cerebral and vascular peripheral diseases, announced today that it has successfully completed the merger with Tokyo-based Terumo Corporation, an international manufacturer and provider of general hospital, cardiac, vascular and home healthcare products. The all-cash acquisition of privately-held MicroVention, which was announced last month, will enable Terumo to immediately expand into the growing worldwide market for the endovascular treatment of cerebral aneurysms.

The current endovascular coiling market is estimated to be $225 million and expected to show double-digit growth over the next several years.

MicroVention and its employees and management will continue to operate out of the Company's headquarters in Aliso Viejo. The existing management team and all MicroVention employees will remain in place and in their current roles.

About MicroVention, Inc.

MicroVention, Inc. (www.microvention.com) is a privately-held medical device company dedicated to the development and commercialization of new catheter-based technologies for the endovascular treatment of cerebral and peripheral vascular diseases. The company has received 510(k) clearance and CE Mark for both its MicroPlex Coil System and the HydroCoil Embolization System to treat cerebral aneurysms. MicroVention sells its products through its direct sales force in the U.S., Canada, France, Germany and the United Kingdom and through distributors in other countries.

About Terumo Corporation

Terumo Corporation (www.terumo.co.jp), headquartered in Shibuya-ku, Japan, is a leading manufacturer of single-use medical devices, such as syringes, blood bags and IV solutions. Terumo has the largest share of the world markets for angiography guide wires and perfusion products and is a leading developer of interventional products, such as catheters and stents. The company was founded in 1921 and its products are distributed in more than 150 countries world wide.

MicroVention, Inc.

CONTACT: Michael Kleine, President, or William Hughes, Vice President,CFO, both of MicroVention, Inc., +1-949-461-3314, or Fax, +1-949-461-3329;or media, Matt Clawson of Allen & Caron, Inc., +1-949-474-4300, or Fax,+1-949-474-4330, for MicroVention, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES